by Maria Zannes | Mar 24, 2022 | Events
Maria Zannes, President & CEO, will discuss keys to a start-up company’s success as part of San Antonio BioMed’s BioFest Invest event on March 30, 2022. Zannes will be on a panel of CEOs presenting to investors, companies and business leaders at the annual spring...
by Maria Zannes | Dec 6, 2021 | Events
bioAffinity discoveries lead to novel approach that kills cancer cells without harm to normal cells by using siRNAs to selectively target multiple cancers DECEMBER 6, 2021 (SAN ANTONIO, TX) bioAffinity Vice President of Research David Elzi, Ph.D., will discuss how...
by Maria Zannes | Sep 29, 2021 | Events
Vice President of Research David Elzi, PhD, will present groundbreaking research leading to bioAffinity’s discovery of how silencing two cell receptors results in cancer cell toxicity, while normal cells are unaffected. His presentation at the American Society of...
by Maria Zannes | Sep 10, 2021 | Events
bioAffinity Technologies President and CEO Maria Zannes will present the Company’s recent advancements in commercializing CyPath® Lung, a noninvasive test to diagnose early stage lung cancer and meet with investors at H.C. Wainwright & Company’s 23rd Annual Global...
by Maria Zannes | Jun 23, 2021 | Events, Press Releases
JUNE 23, 2021 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held biotech company, will present the Company’s discoveries in the field of cancer diagnostics and therapeutics at the RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium June 23 – 25,...
by Maria Zannes | Jun 8, 2021 | Events
Dr. Elzi will present his poster “Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” at the University of Massachusetts RNA Therapeutics Symposium: From Concept to Clinic, June 23-25, 2021. Dr. Elzi’s live presentation will...
